Adverse Events

Two aardvarks
Biotech

Aardvark halts obesity trials, putting entire pipeline on pause

The voluntary pause comes less than a month after Aardvark paused a phase 3 trial for a related asset due to cardiac concerns.
Darren Incorvaia Mar 24, 2026 4:00am
Closeup of blue eye on black background

Kalaris pauses eye drug trial to resolve ocular inflammation

Mar 11, 2026 6:30am
Aardvark

Aardvark pauses ph. 3 hunger trial over 'cardiac observations'

Mar 2, 2026 4:40am
Make a delay and accumulation of outstanding tasks Full stop

Accent halts DHX9 inhibitor trial over adverse events

Feb 26, 2026 5:01am
pause button on blue background

UniQure halts mid- to high-dosing for AAV gene therapy

Feb 6, 2026 10:56am
Make a delay and accumulation of outstanding tasks Full stop

Brain tumor prompts FDA hold for 2 Regenxbio gene therapies

Jan 28, 2026 9:42am